COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Cash & Equivalents	22,765	52,301	45,928	37,362	55,108	52,122
Cash & Short-Term Investments	22,765	52,301	45,928	37,362	55,108	52,122
Cash Growth	23.39%	13.88%	22.93%	-32.20%	5.73%	174.01%
Accounts Receivable	672	637	452	198	100	108
Other Receivables	-	11,562	9,769	8,379	6,519	5,771
Receivables	672	12,199	10,221	8,577	6,619	5,879
Inventory	88,059	86,173	77,479	66,363	60,549	53,560
Prepaid Expenses	-	2,568	2,429	2,189	1,944	1,821
Other Current Assets	15,367	1,092	1,028	980	905	768
Total Current Assets	126,863	154,333	137,085	115,471	125,125	114,150
Property, Plant & Equipment	320,043	295,798	259,464	225,286	195,131	185,374
Long-Term Investments	-	23,456	21,601	19,895	18,831	18,818
Other Intangible Assets	431	497	547	433	326	268
Long-Term Deferred Tax Assets	-	2,461	2,268	1,966	1,904	1,671
Other Long-Term Assets	26,764	1	2	1	1	2
Total Assets	474,101	476,546	420,967	363,052	341,318	320,283
Accounts Payable	156,818	179,549	161,852	139,224	133,041	136,532
Accrued Expenses	-	8,057	7,272	6,234	5,366	5,304
Short-Term Debt	4,000	4,581	2,741	1,387	1,486	1,486
Current Portion of Leases	-	1,931	1,744	1,669	1,609	1,606
Current Income Taxes Payable	6,677	17,420	16,787	12,234	16,723	15,117
Other Current Liabilities	24,163	1,691	1,657	1,315	1,312	1,905
Total Current Liabilities	195,664	213,229	192,053	162,063	159,537	161,950
Long-Term Debt	20,523	23,385	10,018	3,000	4,088	5,574
Long-Term Leases	-	4,166	3,698	3,357	3,261	3,455
Other Long-Term Liabilities	7,178	2,574	2,491	2,644	2,519	2,468
Total Liabilities	225,279	245,105	209,896	172,546	170,740	174,607
Common Stock	4,178	4,178	4,178	4,178	4,178	4,178
Additional Paid-In Capital	5,101	5,101	4,610	4,610	4,610	4,610
Retained Earnings	239,674	222,284	202,485	181,954	162,065	137,185
Treasury Stock	-227	-225	-242	-241	-238	-238
Comprehensive Income & Other	96	103	40	5	-37	-59
Shareholders' Equity	248,822	231,441	211,071	190,506	170,578	145,676
Total Liabilities & Equity	474,101	476,546	420,967	363,052	341,318	320,283
Total Debt	28,529	34,063	18,201	9,413	10,444	12,121
Net Cash (Debt)	-5,764	18,238	27,727	27,949	44,664	40,001
Net Cash Growth	-	-34.22%	-0.79%	-37.42%	11.66%	677.17%
Net Cash Per Share	-72.72	230.16	350.10	352.90	563.95	505.07
Filing Date Shares Outstanding	79.26	79.26	79.2	79.2	79.2	79.2
Total Common Shares Outstanding	79.26	79.26	79.2	79.2	79.2	79.2
Working Capital	-68,801	-58,896	-54,968	-46,592	-34,412	-47,800
Book Value Per Share	3139.42	2920.11	2665.11	2405.44	2153.81	1839.38
Tangible Book Value	248,391	230,944	210,524	190,073	170,252	145,408
Tangible Book Value Per Share	3133.98	2913.84	2658.21	2399.98	2149.70	1836.00

Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.